Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils

Thorax

Volumn 60, Issue 7, 2005, Pages 538-544

  Oudijk, E J D ^a   Nijhuis, E H J ^a   Zwank, M D ^a   Van De Graaf, E A ^a   Mager, H J ^b   Coffer, P J ^a   Lammers, J W J ^a   Koenderman, L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Cardio Thoracic Surgery   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; INFLAMMATION; LEUKOCYTE; MUSCLE ATROPHY; NEUTROPHIL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CYTOKINES; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUTROPHILS; POLYMERASE CHAIN REACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA; VITAL CAPACITY;

EID: 22044433727     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.034009     Document Type: Article

References (31)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
2. Fabbri L, Pauwels RA, Hurd S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary updated 2003. J COPD 2004;1:105-41.
3. Cosio MG, Guerassimov A. Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med 1999;160:521-5.
4. Vernooy JH, Kucukaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002;166:1218-24.
5. Jeffery PK. Comparison of the structural and inflammatory features of COPD and asthma. Giles F Filley Lecture. Chest 2000;117:251-60S.
6. 1. Am J Respir Crit Care Med 1997;155:852-7.
7. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997;155:449-53.
8. Pesci A, Balbi B, Majori M, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998;12:380-6.
9. Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:349-55.
10. Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003;46:5-13s.
11. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1179-84.
12. Noguera A, Batle S, Miralles C, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001;56:432-7.
13. Koenderman L, Kanters D, Maesen B, et al. Monitoring of neutrophil priming in whole blood by antibodies isolated from a synthetic phage antibody library. J Leukoc Biol 2000;68:58-64.
14. Pals CM, Verploegen SA, Raaijmakers JA, et al. Identification of cytokine-regulated genes in human leukocytes in vivo. J Allergy Clin Immunol 2000;105:760-8.
15. Yousefi S, Cooper PR, Mueck B, et al. cDNA representational difference analysis of human neutrophils stimulated by GM-CSF. Biochem Biophys Res Commun 2000;277:401-9.
16. Verploegen S, van Leeuwen CM, van Deutekom HW, et al. Role of Ca2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions. Comparison with the role of phosphotidylinositol- 3 kinase. Eur J Biochem 2002;269:4625-34.
17. Kreuzer KA, Lass U, Landt O, et al. Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem 1999;45:297-300.
18. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002;121:151-55.
19. Fujishima S, Hoffman AR, Vu T, et al. Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-alpha, and IL-1 beta. J Cell Physiol 1993;154:478-85.
20. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999;73:369-509.
21. Malyak M, Smith MF Jr, Abel AA, et al. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol 1994;14:20-30.
22. Yamashiro S, Wang JM, Yang D, et al. Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood 2000;96:3958-63.
23. Iking-Konert C, Wagner C, Denefleh B, et al. Up-regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease. Clin Exp Immunol 2002;130:501-8.
24. Colotta F, Re F, Muzio M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993;261:472-5.
25. Carter DB, Deibel MR Jr, Dunn CJ, et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990;344:633-8.
26. Jawa RS, Quaid GA, Williams MA, et al. Tumor necrosis factor alpha regulates CXC chemokine receptor expression and function. Shock 1999;11:385-90.
27. Khandaker MH, Xu L, Rahimpour R, et al. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J Immunol 1998;161:1930-8.
28. Soejima K, Fujishima S, Nakamura H, et al. Downmodulation of IL-8 receptors, type A and type B, on human lung neutrophils in vivo. Am J Physiol 1997;273:L618-25.
29. Arend WP. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist. Semin Arthritis Rheum 2001;30:1-6.
30. Schiff MH. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann Rheum Dis 2000;59(Suppl 1):i103-8.
31. Malcolm KC, Arndt PG, Manos EJ, et al. Microarray analysis of lipopolysaccharide-treated human neutrophils. Am J Physiol Lung Cell Mol Physiol 2003;284:L663-70.